TrialNeuro-oncology2018

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.

Niklas Schäfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.